Positive human immunodeficiency virus (HIV) or human T-cell lymphotrophic virus (HTLV)-1 serology
Negative human T-lymphotropic virus (HTLV)-1 and 2 antibodies.
EXCLUSION - PROCUREMENT: Active infection with human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)
PROCUREMENT EXCLUSION: Active infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus (HTLV) (can be pending at this time)
No known history of human immunodeficiency virus (HIV) 1 and 2, human T-cell lymphotropic virus (HTLV)-I/II, and hepatitis B and C
PART I: Negative serology for anti-human immunodeficiency virus (HIV)-1/2 and anti-human T-lymphotropic virus (HTLV) 1/2
Patients must have serum antibodies directed to human T-cell lymphotropic virus (HTLV)-1
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Seropositivity for human T-lymphotropic virus type 1 (HTLV-1).
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Donors who are human immunodeficiency virus (HIV)-1, HIV-2, human T-lymphotropic virus (HTLV)-1, HTLV-2 seropositive or with active hepatitis B or hepatitis C virus infection
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) seropositive status
Known infection with Human Immunodeficiency Virus (HIV) or Human T-lymphotropic Virus 1 (HTLV-1).
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) seropositive status
Seronegative for human T-cell lymphotropic virus type 1 (HTLV-1)
Positive results for the human T-lymphotrophic 1 virus (HTLV-1)
Patients with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1) are not eligible
Subject has positive test result at the screening visit for one or more of the following:\r\n* Human T-cell lymphotropic virus (HTLV-1/2)\r\n* Anti-human immunodeficiency virus (HIV) 1 antibody (alpha-HIV-1)
EXCLUSION CRITERIA FOR ENROLLMENT: Human immunodeficiency virus (HIV)-1/2 or human T-cell lymphotropic virus (HTLV)-1/2 positivity
Human immunodeficiency virus (HIV) or human T-cell leukemia virus type (HTLV)1/HTLV2 (seropositivity and/or polymerase chain reaction [PCR] positivity)
Active symptomatic fungal, bacterial and/or viral infection including evidence of infection with human immunodeficiency virus (HIV), human T-cell leukemia virus 1 (HTLV-1) seropositive status
Subject has positive test result at the screening visit for one or more of the following: human T-lymphotropic virus (HTLV)-1/2 and/or anti-human immunodeficiency virus (HIV) 1 antibody (alpha-HIV-1)
Known history of infection with human immunodeficiency virus (HIV) or human T cell leukemia virus 1 (HTLV-1)
Active infection with human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV)
History of positive serology tests for human immunodeficiency virus (HIV) 1 and 2, human T cell lymphotropic virus (HTLV)-1, hepatitis B and C
DONOR: HIV or human T-lymphotropic virus (HTLV) seropositive
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
Active infection with human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV), human T-cell lymphotropic virus (HBV), hepatitis C virus (HCV) (can be pending at this time)
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human t-lymphotrophic virus (HTLV) -I/II
Seropositivity for human T-lymphotropic virus type 1 (HTLV-1)
Human immunodeficiency virus (HIV)-1/HIV-2 or human T-lymphotropic virus (HTLV)-1/HTLV-2 seropositivity
Patients with evidence of human immunodeficiency virus (HIV) seropositivity and/or positive polymerase chain reaction (PCR) assay, human T-cell leukemia virus type (HTLV)1/HTLV2 seropositivity
Known human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) infection
Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Participants with known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus-1 (HTLV-1)
Patient is positive for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus-1 (HTLV-1)
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV)-I/II
Active infections including human T-lymphotropic virus (HTLV) 1 and 2, and human immunodeficiency virus (HIV) 1 and 2
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-lymphotrophic virus (HTLV)-I/II
Seronegativity for human immunodeficiency virus (HIV), human T-cell lymphotropic virus (HTLV1), hepatitis
Human T-lymphotropic virus (HTLV)-1/2
Patient seropositive for human immunodeficiency virus (HIV)-I/II; human T-cell lymphotropic virus (HTLV) -I/II
Positive test results for human T-lymphotropic virus type I (HTLV 1) virus in endemic countries
DONOR: Human immunodeficiency virus (HIV) or human T-lymphotrophic virus (HTLV) infection
Known human immunodeficiency virus (HIV) or human T-lymphotropic virus, type I (HTLV-I) positive status
Human immunodeficiency virus (HIV) or Human T Cell Lymphotropic Virus 1 (HTLV-1) infection
Human immunodeficiency virus (HIV) or human T-lymphotropic virus (HTLV)-I/II
Human immunodeficiency virus (HIV) infection or Human T Cell Lymphotropic Virus 1 (HTLV-1) infection
Has a known human T-lymphotropic virus type 1 (HTLV) infection
Known infection with human immunodeficiency virus (HIV) or human T-cell leukemia virus 1 (HTLV-1)
Known infection with human immunodeficiency virus (HIV) or Human T-Cell Leukemia Virus 1 (HTLV-1) seropositive status
Known history of human immunodeficiency virus (HIV) seropositive status or known infection with human T-cell leukemia virus 1 (HTLV-1) virus
No known history of human immunodeficiency virus (HIV) 1/2, human T-lymphotropic virus (HTLV)-I/II
Patients seropositive for Human T-Lymphotrophic Virus (HTLV)-I or -II
Positive serology for human immunodeficiency virus (HIV) or human T-cell lymphotropic virus (HTLV) at any time prior to enrollment;
The patient has known positive human immunodeficiency virus (HIV) or known active human t-cell lymphotropic virus (HTLV) I/II disease, whether on treatment or not.
